Andrew Hirsch

Andrew Hirsch is the current Board of Directors at Editas Medicine. Andrew has also served as the Chief Financial Officer at Agios Pharmaceuticals, President & CEO at BIND Therapeutics, and VP, Corporate Strategy and M&A at Biogen Idec. In addition, they were the VP, Finance & Chief Financial Officer at Avila Therapeutics and Epesi Technologies. Hirsch began their career as a Senior Financial Analyst at Stern Stewart & Co.

Andrew Hirsch attended the Wheeler School for their high school education. Andrew then went on to the University of Pennsylvania for their BA, where they studied economics and math. Finally, they attended the Tuck School of Business at Dartmouth for their MBA in general management.